期刊文献+

慢性阻塞性肺疾病急性加重期vWF水平变化及意义 被引量:3

The levels and significance of vWF in patients with acute exacerbations of chronic obstructive pulmonary disease
下载PDF
导出
摘要 目的:探讨不同严重度分级的慢性阻塞性肺疾病急性加重期(AECOPD)患者血浆v WF水平及意义。方法:对24例对照组、21例I、Ⅱ级AECOPD、21例Ⅲ级AECOPD、44例Ⅳ级AECOPD血浆v WF水平进行检测。结果:各级AECOPD患者血浆v WF水平显著高于对照组(P<0.05),不同严重度分级的AECOPD患者血浆v WF水平均存在显著差异(P<0.05)。结论:血浆v WF水平增高提示血管内皮细胞损伤及功能失调,AECOPD患者存在血管内皮细胞损伤及功能失调,对治疗及预后存在不利影响。 Objective: To investigate the levels and significance of vWF in patients with acute exacerbations of chronic obstructive pulmonary disease( AOCEPD). Methods: The levels of vWF in 24 patients in the control group,21 cases I / Ⅱ,21 cases Ⅲ,and 44 cases Ⅳ AECOPD were detected. Results: The plasma levels of vWF in patients of AECOPD were significantly higher( P〈0. 05) than that of control groups,futher,there was a significant( P〈0. 05) difference of m WF levels among different classification of severity in patients with AECOPD. Conclusion: The increased levels of plasma vWF prompt endothelial cell injury and dysfunction,which will cause adverse effects on the treatment and prognosis of AECOPD patients.
出处 《广州医科大学学报》 2015年第1期79-81,共3页 Academic Journal of Guangzhou Medical University
关键词 慢性阻塞性肺疾病 血管性血友病因子 血管内皮细胞 chronic obstructive pulmonary disease vWF vascular endothelial cells
  • 相关文献

参考文献2

二级参考文献4

共引文献498

同被引文献61

  • 1周一军,王佳贺,张锦.肝细胞生长因子抗糖基化终产物诱导内皮细胞凋亡及分子机制[J].中国医科大学学报,2006,35(4):367-370. 被引量:3
  • 2许建英,李筱妍,杜永成,杨丽莉,王淑峰,王红.慢性阻塞性肺疾病急性加重期病原学与肺功能关系的研究[J].中国呼吸与危重监护杂志,2007,6(2):88-92. 被引量:21
  • 3Doi M, Nakano K, Hiramoto T, et al. Significance of pulmonary artery pressure in emphysema patients with mild- to- moderate hypoxemia[ J ]. Respir Med, 2003, 97 (8) : 915-920.
  • 4Tian W, Jiang X, Tamosiuniene R, et al. Blocking macrophage leukotriene b4 prevents endothelial injury and reverses pulmonary hypertension[J]. Sci Transl Med, 2013, 5(200):20Oral 17. DOI: 10.1126/scitranslmed.3006674.
  • 5Sage E, Mercier O, Van den Eyden F, et al. Endothelial cell apoptosis in chronically obstructed and reperfused pulmonary artery [J 1. Respir Res, 2008,9 : 19. DOI: 10.1186/1465-9921-9- 19.
  • 6Liu P, Zhang HM, Tang Y J, et al. Influence of Rho kinase inhibitor fasudil on late endothelial progenitor cells in peripheral blood of COPD patiems with pulmonary artery hypertension [J]. Bratisl Lek Listy, 2015,116(3 ) : 150-153.
  • 7Taraseviciene" Stewart L, KasaharaY, Alger L, et al. Inhibition of the VEGF Receptor 2 combined with chronic hypoxia causes cell death- dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension[J]. FASEB J, 2001, 15(2) :427- 438.
  • 8Zhao YD, Campbell AI, Robb M. Protective role of angiopoietin- 1 in experimental pulmonary hypertension [J ]. Circ Res, 2003,92 (9) :984-991.
  • 9Stefanec T. Endothelial apoptosis: could it havearole in the pathogenesis and treatment of disease? [J]. Chest, 2000, 117 (3) : 841-854.
  • 10Cao Y, Jiang Z, Zeng Z, et al. Bcl-2 silencing attenuates hypoxia- induced apoptosis resistance in pulmonary microvascular endothelial cells [J]. Apoptosis, 2016, 21 (1) : 69- 84. DOI: 10.1007/s10495-015-1184-3.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部